Your Position:Products>Monoclonals/Polyclonals

Sacituzumab ELISA Kit

货号:RB9TDY373018
  • Price:Negotiable
  • Click:492

Product Detail

Product Details

ApplicationsELISA
Detection MethodColorimetric
Sensitivity40.3 ng/mL
Detection Range78.13 - 5, 000 ng/mL
Recovery80-120%
Sample TypePlasma, Serum
Assay TypeQuantitative
Stability and StorageWhen the kit was stored at the recommended temperature for 6 months, the signal intensity decreased by less than 20%. For unopened kits, if you want to prolong the storage time, please store the Standard, Detection A, Detection B and Microplate at - 20℃, the rest reagents should be store at 4℃.
Shipping Condition2-8 ℃
Accession NumberP09758
BackgroundSacituzumab govitecan (sacituzumab govitecan-hziy; Trodelvy™) is a Trop-2-directed antibody conjugated to a topoisomerase I inhibitor (SN-38) that is being developed by Immunomedics for the treatment of solid tumours, including breast cancer. In April 2020, sacituzumab govitecan received accelerated approval in the USA for the treatment of adult patients with metastatic triple-negative breast cancer (mTNBC) who have received at least two prior therapies for metastatic disease. Sacituzumab govitecan is undergoing phase III development for breast cancer in the USA and EU, and phase II development for urothelial cancer. It is also being explored for brain metastases, glioblastoma, endometrial cancer and prostate cancer.
Alternative NamesIMMU-132, hRS7-SN-38, hRS7-SN-38-ADC, hRS7-[CL-SN-38], , 1796566-95-4
NoteFor Research Use Only.